Vivo Capital, LLC Diversified Active

CIK: 0001674712 · Show all filings

Period: Q3 2017 (← Previous) (Next →)

Filing Date: Nov 13, 2017

Total Value ($000): $494,813 (100.0% shares, 0.0% debt)

Holdings (29)

— Biohaven Pharmaceutical Holding Company Ltd 14.9%

Value ($000) $73,893 Shares 1,976,818 Est. Cost $37.38 Unrealized —

ACRS Aclaris Therapeutics 14.9%

Value ($000) $73,780 Shares 2,858,569 Est. Cost $19.11 Unrealized +40.3%

ASND Ascendis Pharma 12.9%

Value ($000) $64,048 Shares 1,766,832 Est. Cost $17.51 Unrealized —

— Nabriva Therapeutics PLC 6.7%

Value ($000) $33,368 Shares 4,074,190 Est. Cost $8.19 Unrealized —

— Kala Pharmaceuticals Inc. 5.3%

Value ($000) $26,470 Shares 1,158,911 Est. Cost $22.84 Unrealized —

— Verona Pharma Plc 4.6%

Value ($000) $22,917 Shares 1,492,951 Est. Cost $13.61 Unrealized —

— Strongbridge Biopharma plc 4.1%

Value ($000) $20,442 Shares 2,962,645 Est. Cost $2.40 Unrealized —

— Selecta Biosciences, Inc. 4.1%

Value ($000) $20,425 Shares 1,119,189 Est. Cost $19.86 Unrealized —

CDXS Codexis, Inc. 4.1%

Value ($000) $20,315 Shares 3,054,825 Est. Cost $3.85 Unrealized +43.6%

— Eiger BioPharmaceuticals 4.0%

Value ($000) $19,658 Shares 1,787,091 Est. Cost $16.42 Unrealized —

— Aimmune Therapeutics, Inc. 3.9%

Value ($000) $19,257 Shares 776,813 Est. Cost $10.99 Unrealized —

— Advanced Accelerator Applications S.A. 3.4%

Value ($000) $16,854 Shares 249,241 Est. Cost $35.30 Unrealized —

— Kadmon Holdings, Inc. 2.3%

Value ($000) $11,167 Shares 3,333,333 Est. Cost $3.35 Unrealized —

— Amyris 1.8%

Value ($000) $9,045 Shares 2,826,711 Est. Cost $3.20 Unrealized —

ZLAB Zai Lab 1.8%

Value ($000) $8,775 Shares 325,000 Est. Cost $27.00 Unrealized —

— Soleno Therapeutics, Inc. 1.5%

Value ($000) $7,642 Shares 14,695,264 Est. Cost $0.52 Unrealized —

AUPH Aurinia Pharmaceuticals Inc. 1.5%

Value ($000) $7,607 Shares 1,213,290 Est. Cost $5.62 Unrealized +12.2%

— Agile Therapeutics, Inc. 1.4%

Value ($000) $6,752 Shares 1,513,975 Est. Cost $6.21 Unrealized —

RGNX Regenxbio Inc. 1.1%

Value ($000) $5,417 Shares 164,403 Est. Cost $12.80 Unrealized +75.8%

— Foamix Pharmaceuticals Ltd. 1.0%

Value ($000) $4,745 Shares 855,000 Est. Cost $9.26 Unrealized —

— Trevena, Inc. 0.9%

Value ($000) $4,406 Shares 1,728,000 Est. Cost $7.67 Unrealized —

— BioPharmX Corporation 0.8%

Value ($000) $4,032 Shares 14,096,338 Est. Cost $0.38 Unrealized —

— Sierra Oncology, Inc 0.8%

Value ($000) $3,779 Shares 2,438,270 Est. Cost $1.55 Unrealized —

CRSP CRISPR Therapeutics AG 0.5%

Value ($000) $2,660 Shares 148,878 Est. Cost $18.69 Unrealized -3.0%

— ReVance Therapeutics, Inc. 0.4%

Value ($000) $2,132 Shares 77,373 Est. Cost $24.38 Unrealized —

— Akari Therapeutics Plc 0.4%

Value ($000) $2,124 Shares 345,850 Est. Cost $14.00 Unrealized —

KALV KalVista Pharmaceuticals, Inc. 0.4%

Value ($000) $2,021 Shares 300,325 Est. Cost $7.13 Unrealized 0.0%

— Sunesis Pharmaceuticals, Inc. 0.2%

Value ($000) $970 Shares 500,000 Est. Cost $3.62 Unrealized —

— Soleno Therapeutics, Inc. (W) 0.0%

Value ($000) $112 Shares 943,858 Est. Cost $0.12 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
—	Biohaven Pharmaceutical Holding Company Ltd	1,976,818	$73,893	14.9%	$37.38	—	Common	G11196105
ACRS	Aclaris Therapeutics	2,858,569	$73,780	14.9%	$19.11	+40.3%	Common	00461U105
ASND	Ascendis Pharma	1,766,832	$64,048	12.9%	$17.51	—	ADR	04351P101
—	Nabriva Therapeutics PLC	4,074,190	$33,368	6.7%	$8.19	—	SHS	G63637105
—	Kala Pharmaceuticals Inc.	1,158,911	$26,470	5.3%	$22.84	—	Common	483119103
—	Verona Pharma Plc	1,492,951	$22,917	4.6%	$13.61	—	ADS	925050106
—	Strongbridge Biopharma plc	2,962,645	$20,442	4.1%	$2.40	—	Ordinary Shares	G85347105
—	Selecta Biosciences, Inc.	1,119,189	$20,425	4.1%	$19.86	—	Common	816212104
CDXS	Codexis, Inc.	3,054,825	$20,315	4.1%	$3.85	+43.6%	Common	192005106
—	Eiger BioPharmaceuticals	1,787,091	$19,658	4.0%	$16.42	—	Common	28249U105
—	Aimmune Therapeutics, Inc.	776,813	$19,257	3.9%	$10.99	—	Common	00900T107
—	Advanced Accelerator Applications S.A.	249,241	$16,854	3.4%	$35.30	—	ADS	00790T100
—	Kadmon Holdings, Inc.	3,333,333	$11,167	2.3%	$3.35	—	Common	48283N106
—	Amyris	2,826,711	$9,045	1.8%	$3.20	—	Common	03236M200
ZLAB	Zai Lab	325,000	$8,775	1.8%	$27.00	—	ADR	98887Q104
—	Soleno Therapeutics, Inc.	14,695,264	$7,642	1.5%	$0.52	—	Common	834203101
AUPH	Aurinia Pharmaceuticals Inc.	1,213,290	$7,607	1.5%	$5.62	+12.2%	Common	05156V102
—	Agile Therapeutics, Inc.	1,513,975	$6,752	1.4%	$6.21	—	Common	00847L100
RGNX	Regenxbio Inc.	164,403	$5,417	1.1%	$12.80	+75.8%	Common	75901B107
—	Foamix Pharmaceuticals Ltd.	855,000	$4,745	1.0%	$9.26	—	SHS	M46135105
—	Trevena, Inc.	1,728,000	$4,406	0.9%	$7.67	—	Common	89532E109
—	BioPharmX Corporation	14,096,338	$4,032	0.8%	$0.38	—	Common	09072X101
—	Sierra Oncology, Inc	2,438,270	$3,779	0.8%	$1.55	—	Common	82640U107
CRSP	CRISPR Therapeutics AG	148,878	$2,660	0.5%	$18.69	-3.0%	NAMEN AKT	H17182108
—	ReVance Therapeutics, Inc.	77,373	$2,132	0.4%	$24.38	—	Common	761330109
—	Akari Therapeutics Plc	345,850	$2,124	0.4%	$14.00	—	ADR	00972G108
KALV	KalVista Pharmaceuticals, Inc.	300,325	$2,021	0.4%	$7.13	0.0%	Common	483497103
—	Sunesis Pharmaceuticals, Inc.	500,000	$970	0.2%	$3.62	—	Common	867328700
—	Soleno Therapeutics, Inc. (W)	943,858	$112	0.0%	$0.12	—	Warrant	834203119